L
upin has reportedly received tentative US Food & Drug Administration (USFDA) approval to sell Niacin oral tablets of strength 500 mg, 750 mg and 1000 mg in the US market. The company has semi-exclusivity for the said drug and will launch the drug after getting final approval from the USFDA. The drug Niacin is used in treatment of cardiovascular diseases as it increases HDL cholesterol levels.
https://www.epicresearch.co/
No comments:
Post a Comment